Barclays PLC Ngm Biopharmaceuticals Inc Transaction History

Barclays PLC

  • $327 Billion
  • Q2 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$1.17 - $1.92 $71,290 - $116,989
-60,932 Reduced 66.82%
30,260 $48,000
Q4 2023

Feb 15, 2024
BUY
$0.6 - $1.31 $31,398 - $68,553
52,331 Added 134.66%
91,192 $78,000
Q3 2023

Nov 07, 2023
SELL
$1.05 - $3.37 $1,605 - $5,152
-1,529 Reduced 3.79%
38,861 $41,000
Q2 2023

Aug 03, 2023
SELL
$2.44 - $4.53 $8,996 - $16,702
-3,687 Reduced 8.36%
40,390 $104,000
Q1 2023

May 04, 2023
SELL
$3.72 - $5.4 $96,076 - $139,465
-25,827 Reduced 36.95%
44,077 $179,000
Q4 2022

Feb 13, 2023
BUY
$3.41 - $12.93 $88,690 - $336,296
26,009 Added 59.25%
69,904 $350,000
Q3 2022

Nov 03, 2022
BUY
$12.59 - $17.67 $232,398 - $326,170
18,459 Added 72.57%
43,895 $575,000
Q2 2022

Aug 12, 2022
BUY
$10.58 - $17.5 $64,167 - $106,137
6,065 Added 31.31%
25,436 $326,000
Q1 2022

May 16, 2022
SELL
$13.81 - $18.6 $502,532 - $676,835
-36,389 Reduced 65.26%
19,371 $295,000
Q4 2021

Feb 14, 2022
BUY
$17.26 - $22.02 $405,592 - $517,447
23,499 Added 72.84%
55,760 $987,000
Q3 2021

Nov 09, 2021
BUY
$20.15 - $26.19 $525,088 - $682,485
26,059 Added 420.17%
32,261 $679,000
Q2 2021

Aug 13, 2021
SELL
$15.06 - $30.03 $306,727 - $611,621
-20,367 Reduced 76.66%
6,202 $123,000
Q1 2021

May 13, 2021
BUY
$24.99 - $31.93 $258,171 - $329,868
10,331 Added 63.62%
26,569 $773,000
Q4 2020

Feb 11, 2021
SELL
$16.21 - $31.44 $148,451 - $287,927
-9,158 Reduced 36.06%
16,238 $492,000
Q3 2020

Nov 12, 2020
BUY
$15.59 - $19.97 $40,003 - $51,243
2,566 Added 11.24%
25,396 $404,000
Q2 2020

Aug 12, 2020
BUY
$11.97 - $23.47 $5,374 - $10,538
449 Added 2.01%
22,830 $450,000
Q1 2020

May 13, 2020
SELL
$10.0 - $19.51 $209,330 - $408,402
-20,933 Reduced 48.33%
22,381 $276,000
Q4 2019

Feb 10, 2020
BUY
$9.97 - $20.28 $143,548 - $291,991
14,398 Added 49.79%
43,314 $800,000
Q3 2019

Nov 14, 2019
SELL
$13.09 - $18.19 $4,934 - $6,857
-377 Reduced 1.29%
28,916 $401,000
Q2 2019

Aug 14, 2019
BUY
$12.56 - $16.6 $367,920 - $486,263
29,293 New
29,293 $428,000

Others Institutions Holding NGM

# of Institutions
5
Shares Held
2.6M
Call Options Held
300
Put Options Held
0
View Full List

About NGM BIOPHARMACEUTICALS INC

NGM Quotes by TradingView
  • Ticker NGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,365,904
  • Description
  • NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...
More about NGM
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email